Complete remission achieved with single agent CNTO 328, an anti-IL-6 monoclonal antibody, in relapsed and refractory myeloma

Clin Lymphoma Myeloma Leuk. 2013 Jun;13(3):333-7. doi: 10.1016/j.clml.2012.12.010. Epub 2013 Jan 10.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Female
  • Humans
  • Multiple Myeloma / drug therapy*
  • Recurrence
  • Remission Induction

Substances

  • Antibodies, Monoclonal
  • siltuximab
pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy